Stock data
Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc. (EBS) reported revenue of US$742.90M and net income of US$52.60M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$742.90M | — | US$100.10M | US$52.60M | — |
| 2024 | US$1.04B | — | -US$108.70M | -US$190.60M | — |
| 2023 | US$1.05B | US$317.60M | -US$726.40M | -US$760.50M | — |
| 2022 | US$1.12B | US$383.00M | -US$170.00M | -US$211.60M | — |
| 2021 | US$1.77B | US$891.30M | US$341.40M | US$219.50M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$234.30M | -US$180.20M | — |
| 2026-03-31 | US$156.10M | US$6.80M | — |
| 2025-12-31 | US$148.70M | -US$54.60M | — |
| 2025-09-30 | US$231.10M | US$51.20M | — |
| 2025-06-30 | US$140.90M | -US$12.00M | — |
| 2025-03-31 | US$222.20M | US$68.00M | — |
| 2024-12-31 | US$194.70M | -US$31.30M | — |
| 2024-09-30 | US$293.80M | US$114.80M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.